MedTrace Logo

Low-dose S-Ketamine and Postpartum Depression in Parturients With Prenatal Depression

NCT03927378 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 364

Last updated 2023-04-04

No results posted yet for this study

Summary

Prenatal depression is an important risk factor of postpartum depression. Low-dose ketamine has been used for depression treatment. As a stereoisomer of ketamine, s-ketamine has similar effects to ketamine in anti-depression. We speculate that, for pregnant women with prenatal depression, low-dose s-ketamine infusion after childbirth may reduce the incidence of postpartum depression.

Conditions

Interventions

DRUG

S-ketamine

S-ketamine (0.2 mg/kg in 20 ml normal saline) is administered by intravenous infusion in 40 minutes after childbirth.

DRUG

Placebo

Placebo (20 ml normal saline) is administered by intravenous infusion in 40 minutes after childbirth.

Sponsors & Collaborators

  • Peking University International Hospital

    collaborator OTHER

  • Hunan Provincial Maternal and Child Health Care Hospital

    collaborator OTHER

  • Nanjing Medical University

    collaborator OTHER

  • Women's Hospital School Of Medicine Zhejiang University

    collaborator OTHER

  • Peking University First Hospital

    lead OTHER

Principal Investigators

  • Dong-Xin Wang, MD, PhD · Peking University First Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-19
Primary Completion
2022-08-03
Completion
2022-08-03

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03927378 on ClinicalTrials.gov